We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Uppsala, Sweden, November 20, 2024. The first participants in Dicot Pharma's Phase 2a clinical study have now been dosed. The company's drug candidate LIB-01 is being developed as a new first-line ...